After After
Before Before

10026 - Rat, Joint Damage, H&E


Surgically-induced knee joint instability in rats by transection of the Anterior Cruciate Ligament (ACLT), partial medial Meniscectomy (pMx) or a combination of both (ACLTpMx), is one of the most commonly used experimental animal models of osteoarthritis (OA), see [1],[2]. It shows very similar anatomical location and histopathological features as the human disease. The model is suitable for studying basic pathophysiological aspects of OA and for the pharmaceutical development of disease-modifying drugs.

The severity of joint destruction can best be demonstrated in coronal histological sections of the whole knee joint; stained with Hematoxilin-Eosin (or Safranin-O-Fast Green, see related APP no. 10027). The most important histopathological hallmarks are surface fibrillation and erosion of the articular cartilage, decrease in chondrocyte number, loss of proteoglycan staining and a sclerosis (thickening) of the subchondral bone plate.

Traditionally, the evaluation of the severity of joint damage is done by subjective semi-quantitative grading of the different histopathological features using defined scoring systems, see [3]. However, even with 'blinding' of the observers and sample randomization, this methodology is prone to bias, suffers from low sensitivity to change and requires considerable experience in histopathology. On the other hand, quantitative digital histomorphometry of cartilage destruction and subchondral bone sclerosis can offer an objective, less time consuming and more sensitive assessment of OA histopathology, see [4].

This APP can be used for quantifying a number of parameters relating to joint damage: Cartilage volume/area, surface fibrillation, cellularity, and bone sclerosis. The APP has been verified in both age-dependency studies and treatment studies. 

Osteoarthritis, Joint, knee, Rat, Hematoxilin-Eosin, ACLT, pMx, ACLTpMx, Cartilage, Chondrocytes, Fibrillation, Bone sclerosis, quantitative, digital pathology, image analysis.

This APP can be used on virtual slides with several sections on each slide. Initially an Analysis Box with a predefined size is placed manually at the medial tibia cartilage, including potential lesion area and excluding osteophytes. 

Cartilage, bone and chondrocytes are located inside the Analysis Box.

On the cartilage surface towards the femur, the surface length and Euclidean length between measurement points can be obtained for calculation of the Fibrillation Index.

The output variables obtained from this APP include:

  • Cartilage area in BOX: Area of cartilage, within Analysis Box

  • Number of chondrocytes in BOX: Number of Chondrocyte profiles, within Analysis Box

  • Solid Bone percent: Percent of solid bone, within Analysis Box

  • Cartilage Surface Length: Length of cartilage border towards the femur, within Analysis Box

  • Cartilage Fibrillation Index = Euclidean Distance/Cartilage Surface Length, within Analysis Box

Auxiliary APPs are used for additional process steps, e.g. finding Region of Interest (ROI).
There are no Auxiliary APPs available.

Execution of this APP is dependent on the standardized staining protocol '10026 - Rat knee joint, Hematoxilin-Eosin, Joint Damage - Staining Protocol', developed by, Dr. Karl Rudolphi and Rolf Keiffer, Sanofi Deutschland GmbH, R&D Aging, Quality of Life.

The protocol is made available electronically upon purchase of the APP.

The APP utilizes the Engine™ and Viewer software modules, where Engine™ offers an execution platform to expand processing capability and speed of image analysis. Viewer gives a fast review together with several types of image adjustment properties ex. outlining of regions, annotations and direct measures of distance, curve length, radius, etc. 
By adding the Author™ module the APP can be customized to fit other purposes. Author™ offers a comprehensive and dedicated set of tools for creating new fit-for-purpose analysis APPs, and no programming experience is required.


This APP was developed for, and validated by, Dr. Karl Rudolphi and Rolf Keiffer, Sanofi Deutschland GmbH, R&D Aging, Quality of Life

1. Gerwin, N., et. al., The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rat, Osteoarthritis & Cartilage 2010, 18 (S3), S24-34, DOI

2. Hayami, T., et. al., Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis, Bone 2006, 38 (2), 234-243, DOI

3. Pritzker, K.P., et. al., Osteoarthritis cartilage histopathology: grading and staging, Osteoarthritis Cartilage 2006, 14 (1), 13-29, DOI

4. Rudolphi, K.A., et. al., Improved assessment by quantitative digital histomorphometry of histopathological changes of articular cartilage in a surgical model of post-traumatic osteoarthritis of the knee joint in rats, Osteoarthritis & Cartilage 2012, 20, S71-S128, DOI

Coronal histological section of rat knee joint, stained with Hematoxilin-Eosin. Analysis box placed at the medial tibia cartilage.
Closeup on medial tibia cartilage with Analysis box
Tissue classified in cartilage, chondrocytes, bone, and bone lacunae. Fibrillation Index measures marked as rulers on cartilage surface.